Greenwich Lifesciences Inc (GLSI) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $28.12
• Market Cap: $362.02M
• EPS: $-1.46
• 52-Week High: $34.10
• 52-Week Low: $7.78

Market Sentiment

Greenwich Lifesciences Inc currently has a Bullish sentiment score of 0.22.

About Greenwich Lifesciences Inc

Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical firm based in Stafford, Texas, focused on developing innovative immunotherapies to combat cancer, particularly targeting HER2/neu-expressing tumors, including breast cancer. The company's lead product candidate, GP2, is designed to bolster the immune system's response against cancer cells, showcasing its potential to address significant unmet medical needs in oncology. With a promising pipeline and a strategic focus on transfo...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Greenwich Lifesciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GLSI pay dividends?

Greenwich Lifesciences Inc (GLSI) does not currently pay a regular dividend.

What is GLSI's market cap?

Greenwich Lifesciences Inc (GLSI) has a market capitalization of $362.02M with a current stock price of $28.12.